StreetAlpha.app
Home › Stocks › HURA

TuHURA Biosciences, Inc. (HURA)

$1.25
▼ −8.09%
LAST CLOSE · NOV 20

TuHURA Biosciences develops experimental cancer treatments for patients whose tumors resist immunotherapy, based in Tampa, Florida. It last closed at $1.25 on Nov 20, down 8.09% on the day. The next earnings report for HURA is expected around Wed, Mar 31, 2027. For the quarter ended Sep 2026, HURA reported EPS of -$0.10. Over its last 8 reports the stock moved an average of 6.8% the session after earnings.

AI Auto Pilots
Is HURA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold HURA.

Key Stats

Last 12 months
Results
Net income
−$29.9M
EPS (diluted)
−$0.50
Free cash flow
−$23.8M
Valuation
Market cap
$82.2M
65.8M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$1.9M
At Sep 30
Debt
$9.2M
At Sep 30
Shareholder equity
$19.0M
Shares outstanding
65.8M
At Nov 10
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2023: $0$0FY2023FY2024: $0$0FY2024FY2025: $0$0FY2025

From HURA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 13). Last 12 months adds up the four latest quarters.

Next report
Mar 31
Estimated date · Time not announced
Reported EPS
-$0.10
Quarter ended Sep 2026
Year ago EPS
-$0.14
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.16Dec '24Mar 2025: -$0.15Mar '25Jun 2025: -$0.21Jun '25Sep 2025: -$0.14Sep '25Dec 2025: -$0.13Dec '25Mar 2026: -$0.13Mar '26Jun 2026: -$0.14Jun '26Sep 2026: -$0.10Sep '26Latest -$0.10
Revenue by quarter
Dec 2024: $0Dec '24Mar 2025: $0Mar '25Jun 2025: $0Jun '25Sep 2025: $0Sep '25Dec 2025: $0Dec '25Mar 2026: $0Mar '26Latest $0
How HURA moved after its last 8 reports
Average move the session after a report ±6.8%
Nov 13, 2026Time not announced−4.1%
Aug 14, 2026Time not announced+7.4%
May 15, 2026After the close+10.4%
Apr 1, 2026Time not announced−9.5%
Nov 14, 2025Time not announced+0.5%
Aug 14, 2025After the close+10.9%
May 15, 2025After the close+2.1%
Apr 1, 2025Time not announced−9.9%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on HURAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on HURA
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on HURA

Technical Analysis

HURA · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 31% below its 20 day and 48% below its 50 day average. It is 63% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 30), oversold. The nearest support is the Pivot S1 at $1.19, and the nearest resistance the Pivot at $1.30.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 12.3%/day
Key levels
$3.4352 week high+174.4%
$2.16Swing high (Sep 14)+72.8%
$2.04200 day average+63.2%
$2.02100 day average+61.6%
$1.8550 day average+48.0%
$1.6420 day average+31.2%
$1.36Pivot R1+8.8%
$1.30Pivot+4.0%
$1.25Last close
$1.19Pivot S1−4.8%
$0.4152 week low−67.2%
Indicators
RSI (14)29.68Oversold below 30Oversold
MACD-0.17Below its signal lineBearish
Stochastic9.4Near the bottom of its rangeOversold
ADX (14)32.1Trending down
Williams %R-98.3Oversold below −80, overbought above −20Oversold
CCI (20)-111.9Oversold below −100, overbought above 100Oversold
Rate of change−23.3%Change over 10 sessionsBearish
ATR (14)$0.15Typical daily range, 12.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for HURA

What happened before

See how HURA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow HURA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How HURA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for HURAHow many large options trades hit HURA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

HURA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼20 buying vs 56 selling
  • ▼Held by funds -3.7 pts
  • ▼Funds holding -13
  • ▼Superinvestors: 0 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding7790−14.4%
In funds' top 1000–
Held by funds10.0%13.7%−3.7 pts
New / increased7 / 1324 / 15−48.7%
Reduced / sold out38 / 1833 / 21+3.7%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See HURA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HURA is in one of them and how their past HURA trades turned out.

HURA in the AI portfolios
Loading…

HURA News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered HURA in an article yet. Here's the latest on the wider market.

HURA in the news

HURA Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Aug 9
Who traded HURA · since 2024
Latest 3 filings
$50K – $100KTraded Jul 13, 2025Filed Aug 9, 2025
$1K – $15KTraded Nov 25, 2024Filed Jan 7, 2025
Laurel LeeExchange
$100K – $250KTraded Oct 18, 2024Filed Nov 21, 2024
PersonTypeAmountTradedFiledDelay
Laurel LeeR · FLBuy$50K – $100KJul 13, 2025Aug 9, 202527 d
Laurel LeeR · FLBuy$1K – $15KNov 25, 2024Jan 7, 202543 d
Laurel LeeR · FLExchange$100K – $250KOct 18, 2024Nov 21, 202434 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About TuHURA Biosciences

TuHURA Biosciences is a clinical stage company based in Tampa, Florida, that develops cancer treatments. Its lead candidate, IFx-2.0, is injected into tumors and is designed to make cancer cells look like bacteria so the immune system attacks them. It is aimed at patients whose cancers do not respond to checkpoint inhibitor drugs. The company is also developing TBS-2025, an antibody for acute myeloid leukemia, and early-stage drugs that target cells which suppress the immune system. Its candidates are not yet approved for sale.

Headquarters
Tampa, FL